JP2013523693A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523693A5 JP2013523693A5 JP2013501851A JP2013501851A JP2013523693A5 JP 2013523693 A5 JP2013523693 A5 JP 2013523693A5 JP 2013501851 A JP2013501851 A JP 2013501851A JP 2013501851 A JP2013501851 A JP 2013501851A JP 2013523693 A5 JP2013523693 A5 JP 2013523693A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- poloxamer
- weight
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims 4
- 229960004194 lidocaine Drugs 0.000 claims 4
- 239000003589 local anesthetic agent Substances 0.000 claims 4
- 229920001983 poloxamer Polymers 0.000 claims 4
- 229960000502 poloxamer Drugs 0.000 claims 4
- -1 polyoxyethylene Polymers 0.000 claims 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- 229920001400 block copolymer Polymers 0.000 claims 3
- 239000004359 castor oil Substances 0.000 claims 3
- 235000019438 castor oil Nutrition 0.000 claims 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 206010000210 abortion Diseases 0.000 claims 1
- 231100000176 abortion Toxicity 0.000 claims 1
- 235000019445 benzyl alcohol Nutrition 0.000 claims 1
- 230000036760 body temperature Effects 0.000 claims 1
- 210000003679 cervix uteri Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000004720 fertilization Effects 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 229940074076 glycerol formal Drugs 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 229960005015 local anesthetics Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229960002409 mepivacaine Drugs 0.000 claims 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 claims 1
- 125000006353 oxyethylene group Chemical group 0.000 claims 1
- 229920001993 poloxamer 188 Polymers 0.000 claims 1
- 229940044519 poloxamer 188 Drugs 0.000 claims 1
- 229920001992 poloxamer 407 Polymers 0.000 claims 1
- 229940044476 poloxamer 407 Drugs 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 229940068968 polysorbate 80 Drugs 0.000 claims 1
- 229960001807 prilocaine Drugs 0.000 claims 1
- MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 claims 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 1
- 238000001248 thermal gelation Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1050321-7 | 2010-04-01 | ||
| SE1050321 | 2010-04-01 | ||
| US32541810P | 2010-04-19 | 2010-04-19 | |
| US61/325,418 | 2010-04-19 | ||
| PCT/EP2011/055009 WO2011121074A1 (en) | 2010-04-01 | 2011-03-31 | Thermogelling anaesthetic compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016081084A Division JP2016185950A (ja) | 2010-04-01 | 2016-04-14 | 熱ゲル化麻酔組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013523693A JP2013523693A (ja) | 2013-06-17 |
| JP2013523693A5 true JP2013523693A5 (enExample) | 2014-05-22 |
| JP5972862B2 JP5972862B2 (ja) | 2016-08-17 |
Family
ID=44502740
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013501851A Active JP5972862B2 (ja) | 2010-04-01 | 2011-03-31 | 熱ゲル化麻酔組成物 |
| JP2016081084A Pending JP2016185950A (ja) | 2010-04-01 | 2016-04-14 | 熱ゲル化麻酔組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016081084A Pending JP2016185950A (ja) | 2010-04-01 | 2016-04-14 | 熱ゲル化麻酔組成物 |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US8834927B2 (enExample) |
| EP (1) | EP2552487B1 (enExample) |
| JP (2) | JP5972862B2 (enExample) |
| KR (1) | KR101792200B1 (enExample) |
| CN (1) | CN102858374B (enExample) |
| AU (1) | AU2011234492B2 (enExample) |
| BR (1) | BR112012024673B1 (enExample) |
| CA (1) | CA2795154C (enExample) |
| CL (1) | CL2012002706A1 (enExample) |
| CY (1) | CY1118396T1 (enExample) |
| DK (1) | DK2552487T3 (enExample) |
| EA (1) | EA023396B1 (enExample) |
| ES (1) | ES2608850T3 (enExample) |
| HR (1) | HRP20161663T1 (enExample) |
| HU (1) | HUE031107T2 (enExample) |
| IL (1) | IL222224A (enExample) |
| LT (1) | LT2552487T (enExample) |
| MX (1) | MX2012011262A (enExample) |
| MY (1) | MY163215A (enExample) |
| NZ (1) | NZ602538A (enExample) |
| PH (1) | PH12012501886A1 (enExample) |
| PL (1) | PL2552487T3 (enExample) |
| PT (1) | PT2552487T (enExample) |
| RS (1) | RS55544B1 (enExample) |
| SG (1) | SG184071A1 (enExample) |
| SI (1) | SI2552487T1 (enExample) |
| SM (2) | SMT201700050T1 (enExample) |
| WO (1) | WO2011121074A1 (enExample) |
| ZA (1) | ZA201206988B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011121074A1 (en) * | 2010-04-01 | 2011-10-06 | Pharmanest Ab | Thermogelling anaesthetic compositions |
| US10220093B2 (en) | 2013-02-28 | 2019-03-05 | Mira Pharma Corporation | Long-acting semi-solid lipid formulations |
| EP2961380B1 (en) * | 2013-02-28 | 2020-04-08 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid formulations and its compositions |
| GB201305622D0 (en) * | 2013-03-27 | 2013-05-15 | Sas Ltd | Composition |
| CA2961660A1 (en) * | 2014-10-01 | 2016-04-07 | Als Mountain Llc | Pharmaceutical composition comprising aspirin, metformin, and serotonin with non-ionic surfactant |
| JP6678946B2 (ja) | 2015-03-25 | 2020-04-15 | テルモ株式会社 | ゲル状局所麻酔剤およびそれを用いたゲル状局所麻酔製剤 |
| EP3375456B1 (en) | 2015-11-12 | 2023-05-03 | Terumo Kabushiki Kaisha | Sustained-release topically administered agent |
| CN105769839B (zh) * | 2016-05-17 | 2019-06-11 | 山西远扬医药科技有限公司 | 一种复方利多卡因药物组合物及其制备方法 |
| CN107149697B (zh) * | 2017-03-24 | 2020-07-31 | 王科 | 一种皮肤表面麻醉敷料、其制备方法及使用方法 |
| US10561606B2 (en) | 2017-12-06 | 2020-02-18 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid gel formulations |
| US11426418B2 (en) | 2017-12-06 | 2022-08-30 | Mira Pharma Corporation | Injectable long-acting semi-solid gel formulations |
| CN108309928A (zh) * | 2018-03-22 | 2018-07-24 | 兆科（广州）眼科药物有限公司 | 一种妇科术后止痛药物组合物及其制备方法 |
| IT201800004036A1 (it) * | 2018-03-28 | 2019-09-28 | Teres Srl | Gel transdermico |
| WO2019217536A1 (en) * | 2018-05-08 | 2019-11-14 | University Of Connecticut | Long-acting local anesthetic formulation |
| CN111840553A (zh) * | 2019-04-15 | 2020-10-30 | 湖州依诺唯新药物制剂有限公司 | 脂性药物制剂及其应用 |
| JP7646175B2 (ja) * | 2019-11-28 | 2025-03-17 | 東洋製薬化成株式会社 | リドカイン含有外用医薬組成物 |
| EP4110293A4 (en) * | 2020-02-25 | 2024-07-10 | The University of North Carolina at Chapel Hill | EUTECTIC-BASED ANESTHESIC COMPOSITIONS AND CORRESPONDING APPLICATIONS |
| WO2022055927A1 (en) * | 2020-09-11 | 2022-03-17 | Ps Therapy Ltd. | Topical compositions and methods of use |
| WO2023150345A1 (en) * | 2022-02-04 | 2023-08-10 | Intact Therapeutics, Inc. | Mesalamine pharmaceutical formulations and methods of use thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1248014B (it) * | 1991-06-07 | 1995-01-05 | Inverni Della Beffa Spa | Preparazioni oftalmiche a rilascio protratto |
| SE9601421D0 (sv) | 1996-04-12 | 1996-04-12 | Astra Ab | New composition |
| US6217900B1 (en) * | 1997-04-30 | 2001-04-17 | American Home Products Corporation | Vesicular complexes and methods of making and using the same |
| JP3782551B2 (ja) * | 1997-06-24 | 2006-06-07 | 鉄郎 高山 | 鎮痛組成物 |
| US6528086B2 (en) | 1999-09-28 | 2003-03-04 | Zars, Inc. | Methods and apparatus for drug delivery involving phase changing formulations |
| KR100416646B1 (ko) | 2000-08-14 | 2004-02-05 | 구주제약주식회사 | 리도카인을 함유한 조루치료용 마이크로에멀젼 하이드로겔 제형의 약학 조성물 |
| GB0120701D0 (en) | 2001-08-24 | 2001-10-17 | Maelor Pharmaceuticals Ltd | Pharmaceutical formulations |
| GB0120702D0 (en) | 2001-08-24 | 2001-10-17 | Maelor Pharmaceuticals Ltd | Anaesthetic formulations |
| BR0313060A (pt) * | 2002-07-29 | 2005-06-28 | Transform Pharmaceuticals Inc | Composições farmacêuticas aquosas de 2,6-diisopropilfenol |
| US20040220283A1 (en) * | 2002-07-29 | 2004-11-04 | Transform Pharmaceuticals, Inc. | Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| AU2003900887A0 (en) | 2003-02-27 | 2003-03-13 | Novasel Australia Pty Ltd | Poloxamer emulsion preparations |
| ES2237298B1 (es) * | 2003-07-16 | 2006-11-01 | Italfarmaco, S.A. | Formulaciones mucoadhesivas semisolidas. |
| US20050084508A1 (en) | 2003-07-22 | 2005-04-21 | Vancaillie Thierry G. | Topical anesthesia formulation for bodily cavities |
| US20080154210A1 (en) | 2004-05-28 | 2008-06-26 | Oryxe | Mixture for Transdermal Delivery of Low and High Molecular Weight Compounds |
| US20070190124A1 (en) | 2004-06-07 | 2007-08-16 | Jie Zhang | Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs |
| AU2006201233B2 (en) | 2006-03-24 | 2010-10-07 | Alan Hewitt | Topical anesthesia formulation for bodily cavities |
| US20070298005A1 (en) | 2006-06-22 | 2007-12-27 | Marie-Josee Thibault | Injectable composition for treatment of skin defects or deformations |
| CA2659344C (en) | 2006-07-31 | 2015-03-17 | Laboratoires Besins International | Treatment and prevention of excessive scarring |
| JP5301205B2 (ja) * | 2008-05-28 | 2013-09-25 | 東興薬品工業株式会社 | ゲル軟膏組成物 |
| WO2011121074A1 (en) * | 2010-04-01 | 2011-10-06 | Pharmanest Ab | Thermogelling anaesthetic compositions |
-
2011
- 2011-03-31 WO PCT/EP2011/055009 patent/WO2011121074A1/en not_active Ceased
- 2011-03-31 SM SM20170050T patent/SMT201700050T1/it unknown
- 2011-03-31 PT PT117149567T patent/PT2552487T/pt unknown
- 2011-03-31 LT LTEP11714956.7T patent/LT2552487T/lt unknown
- 2011-03-31 KR KR1020127028635A patent/KR101792200B1/ko active Active
- 2011-03-31 DK DK11714956.7T patent/DK2552487T3/en active
- 2011-03-31 EA EA201290789A patent/EA023396B1/ru unknown
- 2011-03-31 EP EP11714956.7A patent/EP2552487B1/en active Active
- 2011-03-31 BR BR112012024673-9A patent/BR112012024673B1/pt active IP Right Grant
- 2011-03-31 HR HRP20161663TT patent/HRP20161663T1/hr unknown
- 2011-03-31 HU HUE11714956A patent/HUE031107T2/en unknown
- 2011-03-31 CN CN201180016573.8A patent/CN102858374B/zh active Active
- 2011-03-31 AU AU2011234492A patent/AU2011234492B2/en active Active
- 2011-03-31 US US13/638,511 patent/US8834927B2/en active Active
- 2011-03-31 SI SI201131070A patent/SI2552487T1/sl unknown
- 2011-03-31 CA CA2795154A patent/CA2795154C/en active Active
- 2011-03-31 PL PL11714956T patent/PL2552487T3/pl unknown
- 2011-03-31 RS RS20161049A patent/RS55544B1/sr unknown
- 2011-03-31 MX MX2012011262A patent/MX2012011262A/es active IP Right Grant
- 2011-03-31 MY MYPI2012004370A patent/MY163215A/en unknown
- 2011-03-31 NZ NZ602538A patent/NZ602538A/en unknown
- 2011-03-31 JP JP2013501851A patent/JP5972862B2/ja active Active
- 2011-03-31 PH PH1/2012/501886A patent/PH12012501886A1/en unknown
- 2011-03-31 ES ES11714956.7T patent/ES2608850T3/es active Active
- 2011-03-31 SG SG2012068243A patent/SG184071A1/en unknown
-
2012
- 2012-09-18 ZA ZA2012/06988A patent/ZA201206988B/en unknown
- 2012-09-27 IL IL222224A patent/IL222224A/en active IP Right Grant
- 2012-09-27 CL CL2012002706A patent/CL2012002706A1/es unknown
-
2014
- 2014-02-04 US US14/172,794 patent/US8828437B2/en active Active
- 2014-07-18 US US14/335,563 patent/US9254263B2/en active Active
-
2016
- 2016-04-14 JP JP2016081084A patent/JP2016185950A/ja active Pending
- 2016-12-30 CY CY20161101360T patent/CY1118396T1/el unknown
-
2017
- 2017-01-23 SM SM201700050T patent/SMT201700050B/it unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013523693A5 (enExample) | ||
| NZ602538A (en) | Thermogelling anaesthetic compositions | |
| JP2013523694A5 (enExample) | ||
| JP2011516460A5 (enExample) | ||
| HRP20140716T1 (hr) | Analozi oksitocina | |
| ES3023559T3 (en) | Pharmaceutical composition comprising cannabidiol and hyaluronic acid | |
| Syed et al. | Human leukocyte derived interferon-alpha in a hydrophilic gel for the treatment of intravaginal warts in women: a placebo-controlled, double-blind study | |
| JP2023503373A (ja) | 新規多機能オリゴペプチド | |
| EP2950822A1 (en) | Pharmaceutical composition for protecting wounds, providing hemostasis, or preventing adhesion in the gastrointestinal tract | |
| WO2018049326A1 (en) | Combination gel for sexually transmitted infections | |
| ES2227189T3 (es) | Utilizacion de sucralfato o de octasulfato de sucrosa en la preparacion de medicamentos intravaginales topicos ppara la restauracion del tejido cervical. | |
| JP2018109034A (ja) | 避妊殺菌剤の効果を増強するための組成物および方法 | |
| CN114452298A (zh) | 使用基于藻酸的抗微生物化合物抑制炎症和疾病的组合物和方法 | |
| KR102089117B1 (ko) | 올리고머 락트산을 포함하는 약제학적 조성물 | |
| CN103751098B (zh) | 重组人干扰素α2а阴道膨胀栓及其制备方法和检测方法 | |
| CN103251550A (zh) | 含有秋水仙碱的透皮给药膏剂及其制备方法 | |
| CN102824337B (zh) | 一种治疗家畜子宫内膜炎的凝胶剂及其制备方法 | |
| CN104434885A (zh) | 一种快速释放药物的水溶性高分子膜及制备方法 | |
| CN104138350A (zh) | 一种黄芩素温敏凝胶及其制备方法和应用 | |
| CN115025209B (zh) | 一种含溶菌酶的私护凝胶 | |
| CN111870644A (zh) | 一种治疗妇科疾病的配方及制备方法 | |
| CN105434451A (zh) | 两个用于治疗胃溃疡疾病的黄酮类化合物 | |
| RU2747987C1 (ru) | Композиция для лечения латентной и субклинической папилломавирусной инфекции шейки матки и способ ее применения | |
| CN103463564B (zh) | 一种外用莪术油温敏凝胶及其制备方法 | |
| CA2841851A1 (en) | Composition and method for treating hpv |